• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

ASCRS Live: Improvements with the new CellChek 20

Video

Robert Lin, MD, founder of IQ Laser Vision, discussed the new CellChek 20 at the 2023 ASCRS annual meeting in San Diego.

Robert Lin, MD, founder of IQ Laser Vision, discussed the new CellChek 20 at the 2023 ASCRS annual meeting in San Diego.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Robert Lin, MD:

Hi, I'm Dr. Robert Lin, founder of IQ Laser Vision, also Assistant Clinical Professor at the David Geffen School of Medicine at UCLA. Today I want to talk about something really exciting. I've been performing a lot of ICL, EVO ICL, and we've been checking the endothelial cell counts, and it's been very, very difficult with the little cards.

So in the last two years, we started with the Konan version of the endothelial cell counter, which is often used in all the FDA studies when it relates to endothelial cell counts. And the older XL version was pretty good. But now we have the new CellChek 20 which actually does everything in 40 seconds, even more reproducible, and it automatically goes from one eye to the other. So in 40 seconds, we have all the information we need to safely deliver the best outcomes for our patients when they're having the EVO ICL.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.